SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061535
Filing Date
2023-11-09
Accepted
2023-11-09 07:30:26
Documents
70
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ikna-20230930.htm   iXBRL 10-Q 2757196
2 EX-31.1 ikna-ex31_1.htm EX-31.1 18536
3 EX-31.2 ikna-ex31_2.htm EX-31.2 18603
4 EX-32.1 ikna-ex32_1.htm EX-32.1 18167
  Complete submission text file 0000950170-23-061535.txt   8654081

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ikna-20230930_def.xml EX-101.DEF 198409
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ikna-20230930_pre.xml EX-101.PRE 318293
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ikna-20230930_lab.xml EX-101.LAB 427691
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ikna-20230930.xsd EX-101.SCH 51301
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ikna-20230930_cal.xml EX-101.CAL 60233
64 EXTRACTED XBRL INSTANCE DOCUMENT ikna-20230930_htm.xml XML 1392549
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40287 | Film No.: 231390070
SIC: 2836 Biological Products, (No Diagnostic Substances)